Cancer Research Cell Death Mechanisms and Cancer Therapy  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 392-402, February 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miles, C. P.
Right arrow Articles by O'Neill, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, C. P.
Right arrow Articles by O'Neill, F.

Chromosome Studies of 8 in Vitro Lines of Burkitt's Lymphoma1

Charles P. Miles2 and Frank O'Neill2

Division of Pathology, Sloan-Kettering Institute for Cancer Research, and Memorial Hospital, New York, New York

Of 8 Burkitt lymphoma lines, 4 had classically diploid stemlines, Ogun and Kudi being female, and Raji and EB3, male. EB2 was diploid but with an abnormal near-metacentric marker. SL1 was diploid but with 3 markers. EB1 was subdiploid. Jiyoye was normal male except for trisomy for a 6–12+X chromosome.

As compared with benign cells, the lines tended to show a high incidence of aberration including markers, multiradials, and pulverized metaphase figures. A sporadic marker, RM-1, has been observed in SL1, Jiyoye, and Ogun. Distinctive secondary constrictions occur on a pair of 6–12+X homologs in EB2, EB3, and Jiyoye.

1 This work was supported by Grant DRG 798 from the Damon Runyon Memorial Fund for Cancer Research and by NCI CA08748.

2 Present address: Pathology Department, University of Utah Medical Center, Salt Lake City, Utah.

Received 6/24/66. Accepted 9/28/66.




This article has been cited by other articles:


Home page
Arch Pediatr Adolesc MedHome page
K. F. Hubner and L. G. Littlefield
Burkitt Lymphoma in Three American Children: Clinical and Cytogenetic Observations
Arch Pediatr Adolesc Med, October 1, 1975; 129(10): 1219 - 1223.
[Abstract] [PDF]


Home page
ScienceHome page
R. Glaser and F. J. O'Neill
Hybridization of Burkitt Lymphoblastoid Cells
Science, June 16, 1972; 176(4040): 1245 - 1246.
[Abstract] [PDF]


Home page
ScienceHome page
W. Henle, V. Diehl, G. Kohn, H. zur Hausen, and G. Henle
Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells
Science, September 1, 1967; 157(3792): 1064 - 1065.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.